Fungal Biofilms and Drug Resistance

During infection, fungi frequently transition to a biofilm lifestyle, proliferating as communities of surface-adherent aggregates of cells. Phenotypically, cells in a biofilm are distinct from free-floating cells. Their high tolerance of antifungals and ability to withstand host defenses are two characteristics that foster resilience. Biofilm infections are particularly difficult to eradicate and most available antifungals have minimal activity. Therefore, the discovery of novel compounds and innovative strategies to treat fungal biofilms is of great interest. Although many fungi have been observed to form biofilms, the most well-studied is Candida albicans. Animal models have been developed to simulate common Candida device-associated infections, including those involving vascular catheters, dentures, urinary catheters, and subcutaneous implants. Models have also reproduced the most common mucosal biofilm infections, oropharyngeal and vaginal candidiasis. These models incorporate the anatomical site, immune components, and fluid dynamics of clinical niches and have been instrumental in the study of drug resistance and investigation of novel therapies. This chapter describes the significance of fungal biofilm infections, the animal models developed for biofilm study, and how these models have contributed to development of new strategies for eradication of fungal biofilm infections.

    Related Conference of Fungal Biofilms and Drug Resistance

    June 25-26, 2018

    2nd International Conference on Microbial Pathogenesis & Infectious Diseases

    Vancouver, Canada
    (10 Plenary Forums, 2 Days, 1 Event)
    June 28-29, 2018

    12th World Congress on Biotechnology and Microbiology

    Amsterdam, Netherlands
    June 28-29, 2018

    11th World Microbiology & Immunology Congress

    Amsterdam, Netherlands
    July 02-04, 2018

    10th International Virology Summit

    Vienna, Austria
    July 11-12, 2018

    2nd International Conference on Microbial Ecology & Eco Systems

    Toronto, Ontario, Canada
    (10 Plenary Forums 2 days 1 event)
    July 16-18, 2018 London, UK

    Microbialphysiology 2018

    July 16-17, 2018

    2nd International Conference on Chronic Diseases

    Berlin, Germany
    July 27-28, 2018

    11th International Virology and Microbiology

    Vancouver, Canada
    September 10-11, 2018

    47th World Congress on Microbiology

    London, UK
    September 17-18, 2018

    5th World Congress on Microbial Biotechnology

    Lisbon, Portugal
    September 28-29, 2018

    7th Annual Conference on Microbiology

    San Antonio, Texas, USA
    October 08-09, 2018

    9th International Summit on Clinical Microbiology

    Zurich, Switzerland
    October 15-16, 2018

    International Conference on Microbiome R & D and Biostimulants

    Ottawa, Ontario, Canada
    October 31-November 01, 2018

    2nd Annual Conference on Microbes and Beneficial Microbes

    San Francisco, California, USA
    November 07-08, 2018

    3rd Global Medical Microbiology Summit & Expo

    Alabama, USA
    November 15-16, 2018

    5th World Congress and Expo on Applied Microbiology

    Edinburgh, Scotland
    December 03-04, 2018

    International Conference on Cellular and Molecular Microbiology

    Chicago, Illinois, USA
    December 3-4, 2018

    13th World Congress on Virology and Viral Diseases

    Chicago, Illinois, USA
    December 05-06, 2018

    8th Annual Congress on Clinical Microbiology and Infections

    Vancouver, Canada
    March 04-06, 2019

    9th Global Summit on Microbiology & Infectious Diseases

    Prague, Czech Republic

    Fungal Biofilms and Drug Resistance Conference Speakers